Duerden J M, Gibbons G F
Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, U.K.
Biochem J. 1988 Nov 1;255(3):929-35. doi: 10.1042/bj2550929.
Hepatic lipid synthesis was measured in rats in vivo with 3H2O, and the appearance of label in triacylglycerol and its constituent fatty acid and glycerol moieties was determined. In rats treated with Triton WR1339, the amount of newly synthesized fatty acid secreted as very-low-density lipoprotein (VLDL) triacylglycerol was greater during the dark phase of the diurnal cycle than during the light phase (11.3 versus 4.8 mumol of 3H2O/3 h per g of liver respectively). However, the total mass of VLDL triacylglycerol secreted remained constant, as did the amount of label in the secreted triacylglycerol glycerol. Newly synthesized fatty acids comprised only a small proportion of the total VLDL triacylglycerol fatty acids (TGFA) at both times (dark phase, 7.7%; light phase, 2.4%). Starvation for 24 h resulted in a small increase in the secretion of VLDL triacylglycerol. However, the contribution from newly synthesized fatty acids was decreased. Similar effects were observed in streptozotocin-diabetic animals. During the light and dark phases of the cycle, similar quantities of newly synthesized TGFA entered the hepatic cytosol, and these amounts were much smaller than those secreted as VLDL triacylglycerol. The mass of cytosolic triacylglycerol showed a diurnal variation, with a greater concentration during the light phase than in the dark. In diabetes, the mass of triacylglycerol was increased in the cytosol, as was the incorporation of labelled acylglycerol glycerol. Diabetes also abolished the diurnal variation in the quantity of cytosolic triacylglycerol. In each group of animals the specific radioactivity of the microsomal triacylglycerol was similar to that of the respective newly secreted plasma VLDL. The specific radioactivity of the cytosolic triacylglycerol was only 15.8% (dark phase) or 16.8% (light phase) that of the microsomal triacylglycerol. This increased to 35.5% in the starved animals and 40.2% in the diabetic animals.
用³H₂O在大鼠体内测定肝脏脂质合成,并测定甘油三酯及其组成脂肪酸和甘油部分中标记物的出现情况。在用Triton WR1339处理的大鼠中,作为极低密度脂蛋白(VLDL)甘油三酯分泌的新合成脂肪酸量在昼夜周期的黑暗阶段比光照阶段更多(分别为每克肝脏11.3与4.8 μmol³H₂O/3小时)。然而,分泌的VLDL甘油三酯的总质量保持恒定,分泌的甘油三酯甘油中的标记物量也保持恒定。在两个时间段,新合成脂肪酸仅占总VLDL甘油三酯脂肪酸(TGFA)的一小部分(黑暗阶段为7.7%;光照阶段为2.4%)。饥饿24小时导致VLDL甘油三酯分泌略有增加。然而,新合成脂肪酸的贡献减少。在链脲佐菌素诱导的糖尿病动物中也观察到类似的效果。在昼夜周期的光照和黑暗阶段,相似数量的新合成TGFA进入肝细胞溶质,并且这些量远小于作为VLDL甘油三酯分泌的量。细胞质甘油三酯的质量呈现昼夜变化,光照阶段的浓度高于黑暗阶段。在糖尿病状态下,细胞质中甘油三酯的质量增加,标记的酰基甘油甘油的掺入量也增加。糖尿病还消除了细胞质甘油三酯量的昼夜变化。在每组动物中,微粒体甘油三酯的比放射性与各自新分泌的血浆VLDL相似。细胞质甘油三酯的比放射性仅为微粒体甘油三酯的15.8%(黑暗阶段)或16.8%(光照阶段)。在饥饿动物中这一比例增加到35.5%,在糖尿病动物中增加到40.2%。